Aims: Chronic pancreatitis (CP) is - along with acute pancreatitis - the most frequent cause of diabetes of the exocrine pancreas (DEP). Although insulin deficiency is widely accepted as the major feature of DEP, it is still unclear whether diabetes associated with CP is characterized by additional or different functional defects of the insulin secretory machinery. To identify possible functional defects specifically induced by CP, we performed a cross-sectional study in individuals with normal glucose tolerance (NGT), impaired glucose tolerance (IGT) and diabetes mellitus (DM) comparing patients with and without CP (CP vs. NCP). Methods: We administered an oral glucose tolerance test (OGTT) to all participants and, according to their glucose tolerance, classified them as NGT, IGT and DM. Insulin sensitivity and beta-cell functional parameters were derived from OGTT, hyperglycemic clamp and hyperinsulinemic euglycemic clamp. Results: Studying 146 subjects, we found that beta-cell function and insulin secretion were significantly lower in CP compared to NCP patients. However, when we classified the subjects according to OGTT-derived glucose tolerance, we found no differences in beta-cell function or in insulin sensitivity between CP and NCP with the same glucose tolerance status. Of note, we found that arginine-stimulated insulin secretion is reduced only in subjects with CP and DM compared to NCP subjects with DM. Conclusions: Patients with CP had no specific alterations in insulin secretion and beta-cell function. However, in patients diagnosed with diabetes, we found a lower arginine-stimulated insulin secretion, a marker of reduced functional mass.

Ciccarelli, G., Di Giuseppe, G., Soldovieri, L., Quero, G., Nista, E. C., Brunetti, M., Cinti, F., Moffa, S., Capece, U., Tondolo, V., Mari, A., Gasbarrini, A., Pontecorvi, A., Alfieri, S., Giaccari, A., Mezza, T., Beta-cell function and glucose metabolism in patients with chronic pancreatitis, <<EUROPEAN JOURNAL OF INTERNAL MEDICINE>>, 2024; (12): 1-7. [doi:10.1016/j.ejim.2024.06.007] [https://hdl.handle.net/10807/280118]

Beta-cell function and glucose metabolism in patients with chronic pancreatitis

Ciccarelli, Gea;Di Giuseppe, Gianfranco;Soldovieri, Laura;Quero, Giuseppe;Nista, Enrico Celestino;Brunetti, Michela;Cinti, Francesca;Moffa, Simona;Capece, Umberto;Tondolo, Vincenzo;Gasbarrini, Antonio;Pontecorvi, Alfredo;Alfieri, Sergio;Giaccari, Andrea;Mezza, Teresa
2024

Abstract

Aims: Chronic pancreatitis (CP) is - along with acute pancreatitis - the most frequent cause of diabetes of the exocrine pancreas (DEP). Although insulin deficiency is widely accepted as the major feature of DEP, it is still unclear whether diabetes associated with CP is characterized by additional or different functional defects of the insulin secretory machinery. To identify possible functional defects specifically induced by CP, we performed a cross-sectional study in individuals with normal glucose tolerance (NGT), impaired glucose tolerance (IGT) and diabetes mellitus (DM) comparing patients with and without CP (CP vs. NCP). Methods: We administered an oral glucose tolerance test (OGTT) to all participants and, according to their glucose tolerance, classified them as NGT, IGT and DM. Insulin sensitivity and beta-cell functional parameters were derived from OGTT, hyperglycemic clamp and hyperinsulinemic euglycemic clamp. Results: Studying 146 subjects, we found that beta-cell function and insulin secretion were significantly lower in CP compared to NCP patients. However, when we classified the subjects according to OGTT-derived glucose tolerance, we found no differences in beta-cell function or in insulin sensitivity between CP and NCP with the same glucose tolerance status. Of note, we found that arginine-stimulated insulin secretion is reduced only in subjects with CP and DM compared to NCP subjects with DM. Conclusions: Patients with CP had no specific alterations in insulin secretion and beta-cell function. However, in patients diagnosed with diabetes, we found a lower arginine-stimulated insulin secretion, a marker of reduced functional mass.
2024
Inglese
Ciccarelli, G., Di Giuseppe, G., Soldovieri, L., Quero, G., Nista, E. C., Brunetti, M., Cinti, F., Moffa, S., Capece, U., Tondolo, V., Mari, A., Gasbarrini, A., Pontecorvi, A., Alfieri, S., Giaccari, A., Mezza, T., Beta-cell function and glucose metabolism in patients with chronic pancreatitis, <<EUROPEAN JOURNAL OF INTERNAL MEDICINE>>, 2024; (12): 1-7. [doi:10.1016/j.ejim.2024.06.007] [https://hdl.handle.net/10807/280118]
File in questo prodotto:
File Dimensione Formato  
PIIS0953620524002462.pdf

accesso aperto

Licenza: Creative commons
Dimensione 463.87 kB
Formato Adobe PDF
463.87 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/280118
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact